Olympic gold medalist gymnast Shawn Johnson East had respiratory syncytial virus-related experiences with all 3 of her ...

Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe illness, particularly in infants and ...

Starting Nov. 4, babies born in 2024 can get Beyfortus — also known as nirsevimab — to protect against severe illness from ...

GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...

“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...

GSK (GSK) reported its RSV vaccine Arexvy elicited a robust immune response in people aged 18 to 49 years who were at ...

Important information new parents need to know about Respiratory Syncytial Virus, or RSV. It comes around when the weather ...

The CDC's vaccine policy advisors haven't budged on new RSV guidance, remaining unconvinced that younger adults at higher ...

NOROVIRUS cases have surged over the past two weeks, raising fears as Brits brace for a trio of rampant winter viruses.

The 'tripledemic' is affecting the United Kingdom, with the English anticipating a rise in cases during the winter. Attention ...

Fears have grown that in the coming months the UK could face a surge in flu, a new Covid variant and RSV infections. The NHS ...

FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.